- Generic name
- Upadacitinib
- Strength
- 15 mg
- Dosage form
- Er Tablet
- Manufactured by
- The ACME Laboratories Ltd.
UPA ER Tablet Er Tablet
About UPA ER Tablet 15 mg
The er tablet UPA ER Tablet contains Upadacitinib and is made by The ACME Laboratories Ltd. Upadacitinib is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with moderate to severe active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate.
There are 2 brands of Upadacitinib listed in Bangladesh. The lowest listed price is Upacit XR Tablet 15 mg at ৳ 100 per unit.
What is UPA ER Tablet 15 mg?
The er tablet UPA ER Tablet contains Upadacitinib and is made by The ACME Laboratories Ltd. Upadacitinib is a Janus kinase (JAK) inhibitor. Within the signaling pathway, JAKs phosphorylate and activate Signal Transducers and Activators of Transcription (STATs) which modulate intracellular activity including gene expression. Use it only as your doctor directs.
Uses of UPA ER Tablet
Upadacitinib is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with moderate to severe active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. Your doctor will decide if it is suitable for you.
How to use UPA ER Tablet
Swallow the er tablet with water. UPA ER Tablet is taken by mouth. Do not attempt to inject it yourself. If you miss a dose, ask your doctor or pharmacist what to do. Complete the course exactly as prescribed.
Side effects of UPA ER Tablet
Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
Based on animal studies, Upadacitinib has the potential to adversely affect a developing fetus. The limited human data on use of Upadacitinib in pregnant women are not sufficient to evaluate a drug-associated risk for major birth defects or miscarriage. Thrombosis : Consider the risks and benefits prior to treating patients who may be at increased risk of thrombosis. Tell your doctor about all the other medicines you take.
Frequently asked questions
What does UPA ER Tablet treat?
Upadacitinib is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with moderate to severe active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. Your doctor will decide if it is suitable for you.
How should I take UPA ER Tablet?
Swallow the er tablet with water. UPA ER Tablet is taken by mouth.
Can UPA ER Tablet cause side effects?
Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.
Is UPA ER Tablet safe for everyone?
Based on animal studies, Upadacitinib has the potential to adversely affect a developing fetus. The limited human data on use of Upadacitinib in pregnant women are not sufficient to evaluate a drug-associated risk for major birth defects or miscarriage.
Indications
Pharmacology
Dosage & Administration
Pediatric Use: The safety and efficacy of Upadacitinib in children and adolescents aged 0 to 18 years have not yet been established. No data are available.
Interaction
Strong CYP3A4 Inducers: Upadacitinib exposure is decreased when co-administered with strong CYP3A4 inducers (such as rifampin), which may lead to reduced therapeutic effect of Upadacitinib. Coadministration of Upadacitinib with strong CYP3A4 inducers is not recommended.
Side Effects
Pregnancy & Lactation
Precautions & Warnings
- Serious Infections: Avoid use of Upadacitinib in patients with active, serious infection, including localized infections.
- Malignancy: Consider the risks and benefits of Upadacitinib treatment prior to initiating therapy in patients with a known malignancy.
- Thrombosis: Consider the risks and benefits prior to treating patients who may be at increased risk of thrombosis. Promptly evaluate patients with symptoms of thrombosis and treat appropriately.
- Gastrointestinal Perforations: Use with caution in patients who may be at increased risk.
- Laboratory Monitoring: Recommended due to potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes and lipids.
- Embryo-Fetal Toxicity: Upadacitinib may cause fetal harm based on animal studies. Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception.
- Vaccinations: Avoid use of Upadacitinib with live vaccines.
Overdose Effects
Storage Conditions
Alternative brands of Upadacitinib
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.